ArticleMolecules (Basel, Switzerland)2026
Nano-Delivery System for the Prevention and Control of the Disease.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Kiwifruit soft rot is a major cause of postharvest loss owing to rapid fruit decay during storage. This study focused on kiwifruit soft rot during the postharvest storage stage, when fungal development may be promoted by room temperature and high humidity. Soft rot symptoms were observed in the pericarp and fruit flesh. In this study, carvacrol-loaded nanoliposomes (CAR@NL) were prepared by an O/W emulsification-solvent evaporation method to control kiwifruit soft rot. The physicochemical properties of CAR@NL were characterized by laser particle size analysis, Fourier transform infrared spectroscopy (FTIR), and transmission electron microscopy (TEM). Their antifungal activity and preservation efficacy were evaluated by in vitro antifungal assays and fruit storage experiments. The prepared CAR@NL showed an average particle size of approximately 280 nm, an encapsulation efficiency of 85.75%, and a drug loading capacity of 20.14%, along with favorable sustained-release properties. CAR@NL exhibited strong antifungal activity, with an EC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.